ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726367 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726367; 2) Community: the network communities that were significantly associated with the response to NSC 726367; 3) Molecule: the relationships between components within communities and NSC 726367; 4) MDR: the compounds that were significantly associated with the NSC 726367.

NSC Compound Enrichment Correlation
NSC 756404 GW843682X 0.0415729612483928 0.083795469
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0415729612483928 0.018650986
NSC 87868 2-Phenylethyl isothiocyanate 0.0415729612483928 0.086632368
NSC 123111 Mitomycin derivative T 53 0.0457230037898008 -0.10975382
NSC 16166 Azure B bromide 0.0457230037898008 0.10593192
NSC 20527 5-Bromosalicylic acid p-bromoanilide 0.0457230037898008 0.27849603
NSC 20644 Null 0.0457230037898008 0.26830999
NSC 255980 Null 0.0457230037898008 0.20599957
NSC 268251 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE 0.0457230037898008 0.095413806
NSC 269719 Estr-4-en-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (17.beta.)- 0.0457230037898008 0.072691694
Total:66  Current:51    [First] [Prev] [Next] [Last]